ACN vs AEE Stock Comparison
Scores Breakdown
| Metric | ACN | AEE |
|---|---|---|
| 📈 Growth | 22/30 | 0/30 |
| 💰 Profitability | 18/20 | 12/20 |
| 🏦 Financial Health | 18/20 | 14/20 |
| 💵 Valuation | 16/20 | 12/20 |
| ⚠️ Risk (lower is better) | 4/10 | 7/10 |
| Overall Score | 80/100 | 41/100 |
Side-by-Side Summaries
| ACN Analysis | AEE Analysis |
|---|---|
📈 Growth & Financial TrajectoryOver 8 quarters, revenues moved from $16.41B (2024 Q4) to $18.72B (2026 Q3), a cumulative rise of about 14%. Net income increased from roughly $1.68B to $2.34B, up about 39%, signaling improving operating leverage as scale widens. The trend shows quarterly fluctuations but an overall positive trajectory with gradually rising profitability. 💰 Margins & Cash Flow
🛡️ Balance Sheet & Liquidity
⚠️ Key Drivers & Risks
|
📈 Growth & Financial TrajectoryOver eight quarters, Ameren's revenue progressed from $2.173B in 2024 Q2 to $2.176B in 2026 Q1, essentially flat. A standout spike occurred in 2025 Q3 at $2.699B, followed by a dip to $1.782B in 2025 Q4, then a return toward $2.2B. Net income moved unevenly, starting at $457M (Q2 2024) and ending at $358M (Q1 2026), with a peak of $640M in 2025 Q3. 💰 Margins & Cash FlowOperating margins fluctuated, averaging around 24.6%, peaking at 39.3% (2025 Q1) and dipping to 10.2% (2024 Q4). Cash flow: net cash from operating activities was generally positive; investing activities were typically negative, and financing activity provided offsetting support in several quarters. The quarterly cadence yields solid operating cash flow in aggregate, aligning with a capital-intensive utility model. 🛡️ Balance Sheet & LiquidityTotal assets run near $49.8B with liabilities around $36.2B and equity of about $13.6B. Long-term debt sits near $19.4B, indicating a moderate debt load for a regulated utility. The balance sheet remains constructive, supported by recurring operating cash flows. ⚠️ Key Drivers & Risks
|